Christoph H

Biography

Professor Christoph Huber is Emeritus Professor of Medicine at the Medical School of the Johannes Gutenberg University in Mainz, co-founder and board member of the Translational Oncology research organization and co-founder and Head of Supervisory Board at the Cluster for individualized immune intervention (CI-3). From 1990 until 2009 he directed the Hematology-Oncology Department of the Johannes-Gutenberg University (JGU) in Mainz. Under his lead the department was newly built, expanded and completely restructured with a strong and internationally recognized focus on basic and applied tumor and transplantation immunology and translational research. After his studies at Medical School of the Leopold Franzens University in Innsbruck, Christoph Huber gained experience as a health professional of internal medicine and received his Ph.D. Several research scientist visits (Dept. Tumor Biology of Karolinska Institute, Stockholm, Wallenberg Laboratorium, Dept. Immunology of Uppsala University) were followed by an education in clinical bone marrow transplantation at the Fred Hutchinson Cancer Research Center, Seattle. Back in Innsbruck, Dr Huber headed the bone marrow transplantation section of the Department of Internal Medicine, becoming Professor of Clinical Immunobiology. He also co-founded the biopharmaceutical companies Ganymed Pharmaceuticals and BioNTech and serves on both of their boards.   He is a member of numerous scientific committees, in particular the international Association of Cancer Immunotherapy (CIMT), which he co-founded and chairs. Dr Huber is also scientific advisor of multiple biotech companies in Germany, UK and USA, and advisor of leading European strategic investors. He is the author of more than 250 publications, among them various articles in “Nature”, “Nature Immunology”, “Immunity”, and the “Journal of Experimental Medicine”.

Research Interest

Pharmaceutical Sciences